Novo Nordisk is a world leader in diabetes care and insulin products. In addition, the Danish company has a leading position in areas such as haemostasis management, growth hormone therapy, and hormone replacement therapy. Julia Puppe spoke with CEO Lars Rebien Sørensen about diabetes: how to profit from it, and how to prevent it.
Noninvasive system detects drug effects that brachial measurements miss
Finding experienced investigators for clinical trials has become one of the greatest, rate limiting obstacles to rapidly launching studies. Three trends do not bode well for future clinical research productivity:
In the late-1980s, while tending to critically ill adults and children in the intensive care unit of the London teaching hospital where he worked, Dr. James M. Pusey had a realization that changed his career path, his life and his address.